companies > B > Bristol-Myers Squibb Bristol-Myers Squibb Eli Lilly to acquire ImClone for $6.5 billion 06 October 2008 Mystery buyer Eli Lilly reported to outbid Bristol-Myers with $6.1 billion for ImClone 04 October 2008 Bristol-Myers Squibb raises bid for ImClone to $4.7 billion 23 September 2008 Bristol-Myers Squibb files IPO registration for Mead Johnson 16 September 2008 ImClone rejects Bristol-Myers Squibb's $4.3 billion bid; cites $6.1 billion fresh offer 10 September 2008 Carl Icahn finds Bristol-Myers' offer for ImClone Systems low 04 August 2008 Bristol-Myers Squibb completes sell-off of ConvaTec to PE firms 04 August 2008 Letter from James M Cornelius to Carl Icahn 31 July 2008 Bristol-Myers Squibb to acquire ImClone Systems for $4.5-billion 31 July 2008 Bristol-Myers Squibb to buy anti-cancer drug maker Kosan Biosciences for $190 million 30 May 2008 Bristol-Myers Squibb sells ConvaTec to PE firms for $4.1 billion 03 May 2008 Bristol-Myers Squibb will cut jobs, close plants, to save $1.5 billion 07 December 2007 Bristol-Myers Squibb likely to cut 4,300 jobs 01 December 2007 Accenture and Bristol-Myers Squibb launch pharmaceutical industry''s first joint centre for pharmacovigilance 14 September 2007 Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb 14 March 2007 Bristol-Myers Squibb to spin off orthopaedics unit 06 July 2001  search domain-b    go
Legal Policy | Copyright © 1999-2008 The Information Company Private Limited. All rights reserved.